Novedosos péptidos y su uso en diagnóstico y tratamiento

Holmdahl Rikard

2020-01-01

Abstract:Un peptido de entre 8 y 20 aminoacidos que comprende al menos 8 residuos de aminoacidos consecutivos con una secuencia presente en la SEQ ID No 46, en el que al menos uno de los 8 residuos de aminoacidos consecutivos seleccionados de la secuencia presente en la SEQ ID No 46 es citrulina.

What problem does this paper attempt to address?

Virus-Derived Peptides for Clinical Applications

Mingying Yang,Kegan Sunderland,Chuanbin Mao

DOI: https://doi.org/10.1021/acs.chemrev.7b00100

IF: 62.1

2017-01-01

Chemical Reviews

Abstract:Novel affinity agents with high specificity are needed to make progress in disease diagnosis and therapy. Over the last several years, peptides have been considered to have fundamental benefits over other affinity agents, such as antibodies, due to their fast blood clearance, low immunogenicity, rapid tissue penetration, and reproducible chemical synthesis. These features make peptides ideal affinity agents for applications in disease diagnostics and therapeutics for a wide variety of afflictions. Virus-derived peptide techniques provide a rapid, robust, and high-throughput way to identify organism-targeting peptides with high affinity and selectivity. Here, we will review viral peptide display techniques, how these techniques have been utilized to select new organism-targeting peptides, and their numerous biomedical applications with an emphasis on targeted imaging, diagnosis, and therapeutic techniques. In the future, these virus-derived peptides may be used as common diagnosis and therapeutics tools in local clinics.
METODOS Y MATERIALES PARA TRATAR AFECCIONES INFLAMATORIAS USANDO UN POLIPEPTIDO QUE COMPRENDE UN SEGMENTO DE AMINOACIDOS C5 AUTOGENICOS Y UN SEGMENTO DE AMINOACIDOS NO AUTOGENICOS.

Holmdahl Rikard,Hellman Lars T

2009-01-01

Abstract:Uso de una composicion que comprende un adyuvante y un polipeptido para la fabricacion de un medicamento para el tratamiento de la artritis reumatoide en un mamifero, en que dicho polipeptido comprende un segmento de aminoacidos propio del factor C5a del complemento, con una longitud superior a 40 restos de aminoacido, y un segmento de aminoacidos de la proteina ligante de maltosa (MBP) bacteriana, con una longitud superior a 40 restos de aminoacido, y en que dicho polipeptido provoca una respuesta anti-factor C5a propio del complemento en dicho mamifero.
Peptipedia v2.0: A peptide sequence database and user-friendly web platform. A major update

Gabriel Cabas-Mora,Anamaría Daza,Nicole Soto-García,Valentina Garrido,Diego Alvarez,Marcelo Navarrete,Lindybeth Sarmiento-Varón,Julieta H. Sepúlveda Yañez,Mehdi D. Davari,Frederic Cadet,Álvaro Olivera-Nappa,Roberto Uribe-Paredes,David Medina-Ortiz

DOI: https://doi.org/10.1101/2024.07.11.603053

2024-07-16

Abstract:In recent years, peptides have gained significant relevance due to their therapeutic properties. The surge in peptide production and synthesis has generated vast amounts of data, enabling the creation of comprehensive databases and information repositories. Advances in sequencing techniques and artificial intelligence have further accelerated the design of tailor-made peptides. However, leveraging these techniques requires versatile and continuously updated storage systems, along with tools that facilitate peptide research and the implementation of machine learning for predictive systems. This work introduces Peptipedia v2.0, one of the most comprehensive public repositories of peptides, supporting biotechnological research by simplifying peptide study and annotation. Peptipedia v2.0 has expanded its collection by over 45% with peptide sequences that have reported biological activities. The functional biological activity tree has been revised and enhanced, incorporating new categories such as cosmetic and dermatological activities, molecular binding, and anti-ageing properties. Utilizing protein language models and machine learning, more than 90 binary classification models have been trained, validated, and incorporated into Peptipedia v2.0. These models exhibit average sensitivities and specificities of 0.877 ± 0.0530 and 0.873 ±0.054, respectively, facilitating the annotation of more than 3.6 million peptide sequences with unknown biological activities, also registered in Peptipedia v2.0. Additionally, Peptipedia v2.0 introduces description tools based on structural and ontological properties and user-friendly machinelearning tools to facilitate the application of machine-learning strategies to study peptide sequences. Peptipedia v2.0 is accessible under the Creative Commons CC BY-NC-ND 4.0 license at .

Bioinformatics
Analysis of Peptides in Plasma by High Performance Liquid Chromatography Coupled with Electrospray Ionization Mass Spectrometry

Haiyan Fang,Yin Liu,Shufang Wang

DOI: https://doi.org/10.4028/www.scientific.net/amr.340.273

2011-01-01

Advanced Materials Research

Abstract:In this study, a high performance liquid chromatography coupled with electrospray ionization mass spectrometry (HPLC-ESI-MS) method for the determination of eight endogenous peptides, which included angiotensin-II, neurotensin, 5-met-enkephalin, 5-leu-enkephalin, somatostatin, bradykinin, dynorphin A and oxidized glutathione, was developed. MS parameters were optimized in order to obtain the best signal intensity. The optimum MS parameters were: fragmentor: 100 V; nebulizer gas (N2) pressure: 40 psi; drying gas (N2) flow rate: 10 L/min; drying gas temperature: 350 °C; capillary voltage: 2000 V. Validation of the method showed positive results. The correlation coefficients (R2) between the peak areas and the corresponding concentrations of peptides were greater than 0.9903. The limits of detection (LODs) (S/N = 3) of the eight peptides were 3.88 ng/mL ~ 17.5 ng/mL. The developed method had been successfully applied to analyzing the human plasma fortified with the eight peptides, which indicated the potential of the methodology for the analysis of biological sample.
Peptide Selection for Accurate Targeted Protein Quantification Via a Dimethylation High-Resolution Mass Spectrum Strategy with a Peptide Release Kinetic Model

Qi Chen,Yirong Jiang,Yiping Ren,Meirong Ying,Baiyi Lu

DOI: https://doi.org/10.1021/acsomega.9b02002

IF: 4.1

2020-01-01

ACS Omega

Abstract:A crucial step in accurate targeted protein quantification using targeted proteomics is to determine optimal proteotypic peptides representing targeted proteins. In this study, a workflow of peptide selection to determine proteotypic peptides using a dimethylation high-resolution mass spectrum strategy with a peptide release kinetic model was investigated and applied in peptide selection of bovine serum albumin. After specificity, digestibility, recovery, and stability evaluation of tryptic peptides in bovine serum albumin, the optimal proteotypic peptide was selected as LVNELTEFAK. The quantification method using LVNELTEFAK gave a linear range of 1-100 ppm with the coefficient greater than 0.9990, and the detection limit of bovine serum albumin in milk was 0.78 mg/kg. Compared with the proteotypic peptides selected by Skyline, the method showed a better performance in method validation. The workflow exhibited high comprehensiveness and efficiency in peptide selection, facilitating accurate targeted protein quantification in the food matrix, which lack protein standards.
Nouveau Polypeptide, Proteine Humaine 20 Ribosome S4, Et Polynucleotide Codant Pour Ce Polypeptide

Yumin Mao,Yi Xie

2000-01-01

Abstract:L'invention concerne un nouveau polypeptide, une proteine humaine 20 ribosome S4, et un polynucleotide codant pour ce polypeptide ainsi qu'un procede d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l'hemopathie, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action therapeutique ainsi que les applications de ce polynucleotide codant pour la proteine humaine 20 ribosome S4.
Peptide derived from plant defensins: A promising 68Ga radiolabelled agent for diagnostic of infection foci in PET

Jessica Osorio,Roberto Castro Rosas,Mariana Barraco Vega,Ana Laura Reyes,Andrea Paolino,Florencia Menéndez,Mauricio Vega‐Teijido,Eduardo Savio,Javier Giglio,Gianna Cecchetto,Mariella Terán

DOI: https://doi.org/10.1111/cbdd.14578

2024-07-25

Chemical Biology & Drug Design

Abstract:The [68Ga]Ga‐NOTA‐K‐EcgDf1(10) complex was developed as a potential agent for detecting infection foci. It exhibited high radiochemical purity, stability and hydrophilic behaviour. [68Ga]Ga‐NOTA‐K‐EcgDf1(10) showed specific binding to Candida albicans and Aspergillus niger cultures and successful differentiation of infection in PET images with target/non‐target ratios of 3.3 for C. albicans and 3.7 for A. niger. The development of new radiopharmaceuticals for the detection of hidden infection foci has great relevance for early detection and the selection of the correct treatment, particularly in immunosuppressed patients. In that sense, the labelling of antimicrobial peptides (AMPs) that are capable of binding specifically to the pathogenic microorganism which causes the infection, should provide a sufficiently specific agent, able to distinguish an infection from a sterile inflammation. Defensins are particularly interesting molecules with antimicrobial activity, the EcgDf1 defensin was identified from the genome of a Uruguayan native plant, Erythrina crista‐galli, the 'Ceibo' tree. Our group has previously reported a synthetic biologically active short analogue EcgDf21 (ERFTGGHCRGFRRRCFCTKHC) successfully labelled with 99mTc. Herein we present a shorter analogue which also preserves the γ‐core domain, as a pharmacophore for a potential infection detection agent. This peptide was derivatized with the bifunctional chelating agent 1,4,7‐triazacyclononane‐1,4,7‐triacetic acid (NOTA) through a lysine linker in the amino‐terminal group (NOTA‐KGHCRGFRRRC) and radiolabelled with 68Ga ([68Ga]Ga‐NOTA‐K‐EcgDf1(10)). The [68Ga]Ga‐NOTA‐K‐EcgDf1(10) labelling procedure rendered a product with high radiochemical purity and stability in the labelling milieu. The Log P value indicated that the complex has a hydrophilic behaviour, confirmed by the biodistribution profile. The [68Ga]Ga‐NOTA‐K‐EcgDf1(10) complex demonstrated specific binding to cultures of Candida albicans and Aspergillus niger. Its biodistribution showed renal elimination and low accumulation in the rest of the body. It was possible to successfully differentiate sterile inflammation from infection by PET images in nude mice with a target/non‐target ratio of 3.3 for C. albicans and 3.7 for A. niger, respectively.

biochemistry & molecular biology,chemistry, medicinal
Peptimetric: Quantifying and Visualizing Differences in Peptidomic Data

Erik Hartman,Simon Mahdavi,Sven Kjellström,Artur Schmidtchen

DOI: https://doi.org/10.3389/fbinf.2021.722466

2021-08-25

Abstract:Finding new sustainable means of diagnosing and treating diseases is one of the most pressing issues of our time. In recent years, several endogenous peptides have been found to be both excellent biomarkers for many diseases and to possess important physiological roles which may be utilized in treatments. The detection of peptides has been facilitated by the rapid development of biological mass spectrometry and now the combination of fast and sensitive high resolution MS instruments and stable nano HP-LC equipment sequences thousands of peptides in one single experiment. In most research conducted with these advanced systems, proteolytically cleaved proteins are analyzed and the specific peptides are identified by software dedicated for protein quantification using different proteomics workflows. Analysis of endogenous peptides with peptidomics workflows also benefit from the novel sensitive and advanced instrumentation, however, the generated peptidomic data is vast and subsequently laborious to visualize and examine, creating a bottleneck in the analysis. Therefore, we have created Peptimetric, an application designed to allow researchers to investigate and discover differences between peptidomic samples. Peptimetric allows the user to dynamically and interactively investigate the proteins, peptides, and some general characteristics of multiple samples, and is available as a web application at https://peptimetric.herokuapp.com. To illustrate the utility of Peptimetric, we've applied it to a peptidomic dataset of 15 urine samples from diabetic patients and corresponding data from healthy subjects.
De Novo Sequence of Novel Protein Based on Chemically-Assisted Method Using 4-Sulfophenyl Isothiocyanate Derivatization by Mass Spectrometry

Zhou Xin-Wen,Yan Qin,Zhou Pei,Yang Peng-Yuan

DOI: https://doi.org/10.3321/j.issn:0251-0790.2009.04.013

2009-01-01

Abstract:Eight tryptic peptides of a novel ginsenoside Rb1 hydrolase(beta-glucosidase) purified from Paecilomyces bainier were identified with chemically assisted de novo sequencing followed 4-sulfophenyl isothiocyanate (SPITC) derivatization by MALDI-TOF-TOF mass spectrometry. Sonic relatively complete sequences were obtained from sulfonated peptides with very low signal/noise ratio. A pair of peptides were identified with non-oxidation and oxidation at methionine, respectively. The results indicated that the sulfonated peptide by SPITC significantly enhanced MALDI-TOF-PSD fragmentation signals and produced a spectrum containing only y(+) ions. This method facilitated de novo sequencing and spectrum interpretation. By comparing the eight identified peptide sequences with the NCBI database, this purified B-glucosidase proves to be a novel protein that has not yet been reported. Two relatively conserved peptides are remarkable contribution to further research.
Peptides De Novo Sequencing Strategy Based on Pseudo Isobaric Peptide Termini Labeling

Chao Yang,Jian-Hui Liu,Wei-Jie Zhang,Yi-Chu Shan,Zhong-Peng Dai,Li-Hua Zhang,Yu-Kui Zhang

DOI: https://doi.org/10.19756/j.issn.0253.3820.201627

IF: 1.193

2021-01-01

Chinese Journal of Analytical Chemistry

Abstract:Peptide de novo sequencing is of great significance for the functional study of active peptides, discovery of disease-related protein mutants and the quality control of monoclonal antibodies. The peptide de novo sequencing method determines the types of amino acid residues based on the mass differences of ions in the mass spectrum, and then derives the amino acid sequence of the peptide. Due to the presence of noise and interfering ions in mass spectrum, the accuracy of sequencing by current sequencing algorithms is low. In this study, a de novo sequencing method based on pseudo-isobaric peptide termini labeling (PIPTL) was developed. The peptides were divided equally into two parts. For the first part, the N-termini of the peptide was dimethylated with formaldehyde, and the O-16 of the C-terminal carboxyl group was replaced with O-18. For the other part, the N-termini was dimethylated with deuterated formaldehyde. The two labeled peptide samples were mixed in equal. Different labeled peptides of the same sequence differ in precursor mass by only 0.016 Da. These pseudo isobaric peptides could be fragmented at the same time in the mass spectrum to produce paired fragment ions. The developed sequencing algorithm simplified the spectra and effectively extracted and distinguished b/y ions and sequence peptides. This strategy had an accuracy of 95.51% for sequencing tryptic digested bovine serum albumin. The sequencing accuracy was significantly higher than the commercial sequencing software PEAKS. In addtion, the monoclonal antibody Herceptin tryptic peptides were sequenced, and the sequencing accuracy was 93.60%. This method could be applied to the field of characterization of monoclonal antibody sequences.
A Peptide With Delicious Taste

Y. Yamasaki,K. Maekawa

DOI: https://doi.org/10.1271/BBB1961.42.1761

1978-01-06

Abstract:A peptide fraction with a delicious taste was isolated from the gravy of beef meat. By successive application of gel filtration with Sephadex G–25, chromatography on an ion exchange resin (Dowex 50 x 4), and paper electrophoresis, the peptide was purified. The amino acid sequence of the purified peptide was determined by Edman degradation for N-terminal and Cpase A method for C-terminal sequence. As a result, the primary structure of the peptide was proposed as follows; H~Lys-Gly-Asp-Glu-Glu-Ser-Leu-Ala-OH.

Chemistry
Bioinformatic approaches to the identification of novel neuropeptide precursors

Elke Clynen,Feng Liu,Steven J Husson,Bart Landuyt,Eisuke Hayakawa,Geert Baggerman,Geert Wets,Liliane Schoofs

DOI: https://doi.org/10.1007/978-1-60761-535-4_25

Abstract:With the entire genome sequence of several animals now available, it is becoming possible to identify in silico all putative peptides and their precursors in an organism. In this chapter we describe a searching algorithm that can be used to scan the genome for predicted proteins with the structural hallmarks of (neuro)peptide precursors. We also describe how to use search strings such as the presence of a glycine residue as a putative amidation site, dibasic cleavage sites, the presence of a signal peptide, and specific peptide motifs to improve a standard BLAST search and make it suitable for searching (neuro)peptides in EST data. We briefly explain how bioinformatic tools and in silico predicted peptide precursor sequences can aid experimental peptide identification with mass spectrometry.
Peptipedia: a comprehensive database for peptide research supported by Assembled predictive models and Data Mining approaches

Cristofer Quiroz,Yasna Barrera Saavedra,Benjamín Armijo-Galdames,Juan Amado-Hinojosa,Álvaro Olivera-Nappa,Anamaria Sanchez-Daza,David Medina-Ortiz

DOI: https://doi.org/10.48550/arXiv.2101.12210

IF: 4.31

2021-01-28

Genomics

Abstract:Motivation: Peptides have attracted the attention in this century due to their remarkable therapeutic properties. Computational tools are being developed to take advantage of existing information, encapsulating knowledge and making it available in a simple way for general public use. However, these are property-specific redundant data systems, and usually do not display the data in a clear way. In some cases, information download is not even possible. This data needs to be available in a simple form for drug design and other biotechnological applications. Results: We developed Peptipedia, a user-friendly database and web application to search, characterise and analyse peptide sequences. Our tool integrates the information from thirty previously reported databases, making it the largest repository of peptides with recorded activities so far. Besides, we implemented a variety of services to increase our tool's usability. The significant differences of our tools with other existing alternatives becomes a substantial contribution to develop biotechnological and bioengineering applications for peptides. Availability: Peptipedia is available for non-commercial use as an open-access software, licensed under the GNU General Public License, version GPL 3.0. The web platform is publicly available at pesb2.cl/peptipedia. Both the source code and sample datasets are available in the GitHub repository https://github.com/CristoferQ/PeptideDatabase. Contact: david.medina@cebib.cl, ana.sanchez@ing.uchile.cl
Peposx-Exhaust: A Lightweight and Efficient Tool for Identification of Short Peptides

Wanshun Liu,Mouming Zhao,Lishe Gan,Baoguo Sun,Shiqi He,Yang Liu,Lei Li,Jing Chen,Jianan Zhang,Jucai Xu

DOI: https://doi.org/10.1016/j.fochx.2024.101249

2024-01-01

Abstract:Short peptides have become the focus of recent research due to their variable bioactivities, good digestibility and wide existences in food-derived protein hydrolysates. However, due to the high complexity of the samples, identifying short peptides still remains a challenge. In this work, a tool, named PeposX-Exhaust, was developed for short peptide identification. Through validation with known peptides, PeposX-Exhaust identified all the submitted spectra and the accuracy rate reached 75.36%, and the adjusted accuracy rate further reached 98.55% when with top 5 candidates considered. Compared with other tools, the accuracy rate by PeposX-Exhaust was at least 70% higher than two database-search tools and 15% higher than the other two de novo-sequencing tools, respectively. For further application, the numbers of short peptides identified from soybean, walnut, collagen and bonito protein hydrolysates reached 1145, 628, 746 and 681, respectively. This fully demonstrated the superiority of the tool in short peptide identification.
PowerNovo: de novo peptide sequencing via tandem mass spectrometry using an ensemble of transformer and BERT models

Denis V Petrovskiy,Kirill S Nikolsky,Liudmila I Kulikova,Vladimir R Rudnev,Tatiana V Butkova,Kristina A Malsagova,Arthur T Kopylov,Anna L Kaysheva

DOI: https://doi.org/10.1038/s41598-024-65861-0

2024-07-01

Abstract:The primary objective of analyzing the data obtained in a mass spectrometry-based proteomic experiment is peptide and protein identification, or correct assignment of the tandem mass spectrum to one amino acid sequence. Comparison of empirical fragment spectra with the theoretical predicted one or matching with the collected spectra library are commonly accepted strategies of proteins identification and defining of their amino acid sequences. Although these approaches are widely used and are appreciably efficient for the well-characterized model organisms or measured proteins, they cannot detect novel peptide sequences that have not been previously annotated or are rare. This study presents PowerNovo tool for de novo sequencing of proteins using tandem mass spectra acquired in a variety of types of mass analyzers and different fragmentation techniques. PowerNovo involves an ensemble of models for peptide sequencing: model for detecting regularities in tandem mass spectra, precursors, and fragment ions and a natural language processing model, which has a function of peptide sequence quality assessment and helps with reconstruction of noisy sequences. The results of testing showed that the performance of PowerNovo is comparable and even better than widely utilized PointNovo, DeepNovo, Casanovo, and Novor packages. Also, PowerNovo provides complete cycle of processing (pipeline) of mass spectrometry data and, along with predicting the peptide sequence, involves the peptide assembly and protein inference blocks.
CLASSIFICATION AND CHARACTERISATION OF A NEW ANTIMICROBIAL PEPTIDE

Elizaveta A. Ulitina,,Sergey L. Tikhonov,Natalya V. Tikhonova,,

DOI: https://doi.org/10.5922/gikbfu-2024-1-7

2024-01-01

Abstract:In recent years, significant progress has been achieved in AMP research, revealing the potential of these compounds as alternatives to traditional antibiotics. Due to the diverse mechanisms of action and a wide range of antibacterial activity, AMP provides new opportunities for preventing and treating multidrug-resistant infections by creating foods with antimicrobial properties, new antimicrobial biologically active additives and medicines. This study aimed to create, characterise and classify a new AMP. The DRAMP proteomic database was used to design the AMP, and the Peptide Ranker was utilised to predict biological activity (http://distilldeep.ucd.ie/PeptideRanker). The peptide was identified with the help of the EROP-Moscow database (http://erop.inbi.ras.ru/index.html), and its physio-chemical properties were studied using the APD, DRAMP and PepCalc databases (http://pepcalc.com). The research resulted in the design of a new AMP consisting of 11 amino acid residues with the following percentages: Val, Ala, Trp, Gly, Pro, Tyr, Glu, His, Lys by 9 % and Arg by 18 %. The total hydrophobic ratio in the peptide, determined by APD, is 27 %; the total net charge is +2.25. Its molecular formula is C64H96N21O15S0, with protein binding potential (Boman index) at 3.44 kcal/mol. The peptide can form an alpha helix. The resulting peptide can be classified as a synthesised cationic hydrophobic alpha-helical antimicrobial polypeptide.
pNovo+: de novo peptide sequencing using complementary HCD and ETD tandem mass spectra.

Hao Chi,Haifeng Chen,Kun He,Long Wu,Bing Yang,Rui-Xiang Sun,Jianyun Liu,Wen-Feng Zeng,Chun-Qing Song,Si-Min He,Meng-Qiu Dong

DOI: https://doi.org/10.1021/pr3006843

2013-01-01

Journal of Proteome Research

Abstract:De novo peptide sequencing is the only tool for extracting peptide sequences directly from tandem mass spectrometry (MS) data without any protein database. However, neither the accuracy nor the efficiency of de novo sequencing has been satisfactory, mainly due to incomplete fragmentation information in experimental spectra. Recent advancement in MS technology has enabled acquisition of higher energy collisional dissociation (HCD) and electron transfer dissociation (ETD) spectra of the same precursor. These spectra contain complementary fragmentation information and can be collected with high resolution and high mass accuracy. Taking these advantages, we have developed a new algorithm called pNovo+, which greatly improves the accuracy and speed of de novo sequencing. On tryptic peptides, 86% of the topmost candidate sequences deduced by pNovo+ from HCD + ETD spectral pairs matched the database search results, and the success rate reached 95% if the top three candidates were included, which was much higher than using only HCD (87%) or only ETD spectra (57%). On Asp-N, Glu-C, or Elastase digested peptides, 69-87% of the HCD + ETD spectral pairs were correctly identified by pNovo+ among the topmost candidates, or 84-95% among the top three. On average, it takes pNovo+ only 0.018 s to extract the sequence from a spectrum or spectral pair on a common personal computer. This is more than three times as fast as other de novo sequencing programs. The increase of speed is mainly due to pDAG, a component algorithm of pNovo+. pDAG finds the k longest paths in a directed acyclic graph without the antisymmetry restriction. We have verified that the antisymmetry restriction is unnecessary for high resolution, high mass accuracy data. The extensive use of HCD and ETD spectral information and the pDAG algorithm make pNovo+ an excellent de novo sequencing tool.
Development and validation of sensitive sandwich ELISAs for two investigational nonapeptide metastin receptor agonists, TAK-448 and TAK-683

Nobuyo Yoshida,Naoki Nishizawa,Hisanori Matsui,Yuu Moriya,Chieko Kitada,Taiji Asami,Hirokazu Matsumoto

DOI: https://doi.org/10.1016/j.jpba.2012.05.033

Abstract:TAK-448 and TAK-683, investigational agents with potential utility in the treatment of prostate cancer, are potent low molecular weight metastin receptor agonists consisting of nine amino acids. Monoclonal antibodies (mAbs) against these agents were developed to facilitate their evaluation in preclinical studies. Six mAbs were obtained from four immunogens. Three mAbs recognized the C-terminal of TAK-683 and TAK-448, two recognized the N-terminal of TAK-683, and one recognized the N-terminal of TAK-448. Using various combinations of these six mAbs, sandwich ELISAs for TAK-448 and TAK-683 were developed. These assays were highly sensitive, specific, and accurate. The detection limit for TAK-448 and TAK-683 was 3 and 5 pg/mL, respectively, and there was no interference from rat plasma, rat metastin, or analogs of TAK-448/TAK-683. Recovery achieved ≤±10% with intra-/inter-day assay precision coefficient of variation <10%. The assay demonstrated high stability and sample pre-treatment was not required. Each assay detected the dose-dependent concentration of TAK-448 and TAK-683 in blood 24h after a single intravenous administration of 0.1 and 1mg/kg doses. In conclusion, sensitive sandwich ELISAs were developed to detect the small peptides TAK-448 and TAK-683. The novel assays reliably quantified these nonapeptides in rat plasma, and thus will be useful for preclinical studies of these agents. This methodology may be applicable to the development of similar assays for other short peptides.
In Vivo Evaluation of ECP Peptide Analogues for the Treatment of Acinetobacter baumannii Infection

Jiarui Li,Guillem Prats-Ejarque,Marc Torrent,David Andreu,Klaus Brandenburg,Pablo Fernández-Millán,Ester Boix

DOI: https://doi.org/10.3390/biomedicines10020386

IF: 4.757

2022-02-05

Biomedicines

Abstract:Antimicrobial peptides (AMPs) are alternative therapeutics to traditional antibiotics against bacterial resistance. Our previous work identified an antimicrobial region at the N-terminus of the eosinophil cationic protein (ECP). Following structure-based analysis, a 30mer peptide (ECPep-L) was designed that combines antimicrobial action against Gram-negative species with lipopolysaccharides (LPS) binding and endotoxin-neutralization activities. Next, analogues that contain non-natural amino acids were designed to increase serum stability. Here, two analogues were selected for in vivo assays: the all-D version (ECPep-D) and the Arg to Orn version that incorporates a D-amino acid at position 2 (ECPep-2D-Orn). The peptide analogues retained high LPS-binding and anti-endotoxin activities. The peptides efficacy was tested in a murine acute infection model of Acinetobacter baumannii. Results highlighted a survival rate above 70% following a 3-day supervision with a single administration of ECPep-D. Moreover, in both ECPep-D and ECPep-2D-Orn peptide-treated groups, clinical symptoms improved significantly and the tissue infection was reduced to equivalent levels to mice treated with colistin, used as a last resort in the clinics. Moreover, treatment drastically reduced serum levels of TNF-α inflammation marker within the first 8 h. The present results support ECP-derived peptides as alternative candidates for the treatment of acute infections caused by Gram-negative bacteria.
Fundamental Uses of Peptides as a New Model in Both Treatment and Diagnosis

Hend Okasha

DOI: https://doi.org/10.2174/1872208317666230512143508

Abstract:An amino acid short chain is known as a peptide. Peptide bonds are the connections that hold the amino acids of a peptide together in a particular order. Characteristically, the shorter length of peptides helps to identify them from proteins. Different ways are used to classify peptides, including chain length, source of peptides, or their biological functions. The fact that peptides serve several purposes suggests that there is a foundation for improvement in peptide production and structure to enhance action. In addition, many patents on peptides for therapeutic and diagnostic approaches have been obtained. This review aims to give an overview of peptides used recently in treatment and diagnosis.

Novedosos péptidos y su uso en diagnóstico y tratamiento

Virus-Derived Peptides for Clinical Applications

METODOS Y MATERIALES PARA TRATAR AFECCIONES INFLAMATORIAS USANDO UN POLIPEPTIDO QUE COMPRENDE UN SEGMENTO DE AMINOACIDOS C5 AUTOGENICOS Y UN SEGMENTO DE AMINOACIDOS NO AUTOGENICOS.

Peptipedia v2.0: A peptide sequence database and user-friendly web platform. A major update

Analysis of Peptides in Plasma by High Performance Liquid Chromatography Coupled with Electrospray Ionization Mass Spectrometry

Peptide Selection for Accurate Targeted Protein Quantification Via a Dimethylation High-Resolution Mass Spectrum Strategy with a Peptide Release Kinetic Model

Nouveau Polypeptide, Proteine Humaine 20 Ribosome S4, Et Polynucleotide Codant Pour Ce Polypeptide

Peptide derived from plant defensins: A promising 68Ga radiolabelled agent for diagnostic of infection foci in PET

Peptimetric: Quantifying and Visualizing Differences in Peptidomic Data

De Novo Sequence of Novel Protein Based on Chemically-Assisted Method Using 4-Sulfophenyl Isothiocyanate Derivatization by Mass Spectrometry

Peptides De Novo Sequencing Strategy Based on Pseudo Isobaric Peptide Termini Labeling

A Peptide With Delicious Taste

Bioinformatic approaches to the identification of novel neuropeptide precursors

Peptipedia: a comprehensive database for peptide research supported by Assembled predictive models and Data Mining approaches

Peposx-Exhaust: A Lightweight and Efficient Tool for Identification of Short Peptides

PowerNovo: de novo peptide sequencing via tandem mass spectrometry using an ensemble of transformer and BERT models

CLASSIFICATION AND CHARACTERISATION OF A NEW ANTIMICROBIAL PEPTIDE

pNovo+: de novo peptide sequencing using complementary HCD and ETD tandem mass spectra.

Development and validation of sensitive sandwich ELISAs for two investigational nonapeptide metastin receptor agonists, TAK-448 and TAK-683

In Vivo Evaluation of ECP Peptide Analogues for the Treatment of Acinetobacter baumannii Infection

Fundamental Uses of Peptides as a New Model in Both Treatment and Diagnosis